Conversion Therapy to Transplant or Surgical Resection in Patients with Unresectable Hepatocellular Carcinoma Treated with Boosted Dose of Yttrium-90 Radiation Segmentectomy
This study provides further real-world data demonstrating that boosted-dose TARE is an effective modality for conversion of patients with unresectable HCC to transplant or resection.
Authors
- Alice C. Wei (ORCID: https://orcid.org/0000-0002-2505-959X)
- Aaron Maxwell (ORCID: https://orcid.org/0000-0002-9207-7210)
- Ruben Geevarghese (ORCID: https://orcid.org/0000-0002-8461-0011)
- Sam Y. Son (ORCID: https://orcid.org/0000-0002-2003-7930)
- Michael I. D’Angelica (ORCID: https://orcid.org/0000-0002-3731-0534)
- Brett Marinelli (ORCID: https://orcid.org/0000-0003-3220-1360)
- Hooman Yarmohammadi (ORCID: https://orcid.org/0000-0002-3127-9222)
- William R. Jarnagin (ORCID: https://orcid.org/0000-0002-1635-5768)
- Ken Zhao (ORCID: https://orcid.org/0000-0003-2683-1171)
- Anne M. Covey (ORCID: https://orcid.org/0000-0002-1477-8468)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Brown University (US)
Publication Details
- Journal
- Cancers
- Published
- 2024-08-30
- DOI
- https://doi.org/10.3390/cancers16173024
- Citations
- 3
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.11